These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Sequence-specific potent induction of IFN-alpha by short interfering RNA in plasmacytoid dendritic cells through TLR7. Hornung V, Guenthner-Biller M, Bourquin C, Ablasser A, Schlee M, Uematsu S, Noronha A, Manoharan M, Akira S, de Fougerolles A, Endres S, Hartmann G. Nat Med; 2005 Mar; 11(3):263-70. PubMed ID: 15723075 [Abstract] [Full Text] [Related]
11. Design of bifunctional siRNAs: combining immunostimulation and gene-silencing in one single siRNA molecule. Furset G, Sioud M. Biochem Biophys Res Commun; 2007 Jan 19; 352(3):642-9. PubMed ID: 17150189 [Abstract] [Full Text] [Related]
13. Effect of siRNA nuclease stability on the in vitro and in vivo kinetics of siRNA-mediated gene silencing. Bartlett DW, Davis ME. Biotechnol Bioeng; 2007 Jul 01; 97(4):909-21. PubMed ID: 17154307 [Abstract] [Full Text] [Related]
14. Rational design and in vitro and in vivo delivery of Dicer substrate siRNA. Amarzguioui M, Lundberg P, Cantin E, Hagstrom J, Behlke MA, Rossi JJ. Nat Protoc; 2006 Jul 01; 1(2):508-17. PubMed ID: 17406276 [Abstract] [Full Text] [Related]
17. On the delivery of small interfering RNAs into mammalian cells. Sioud M. Expert Opin Drug Deliv; 2005 Jul 01; 2(4):639-51. PubMed ID: 16296791 [Abstract] [Full Text] [Related]
18. Immunostimulatory properties and antiviral activity of modified HBV-specific siRNAs. Shin D, Kim SI, Park M, Kim M. Biochem Biophys Res Commun; 2007 Dec 21; 364(3):436-42. PubMed ID: 17963721 [Abstract] [Full Text] [Related]
19. Chemical modifications on siRNAs avoid Toll-like-receptor-mediated activation of the hepatic immune system in vivo and in vitro. Broering R, Real CI, John MJ, Jahn-Hofmann K, Ickenstein LM, Kleinehr K, Paul A, Gibbert K, Dittmer U, Gerken G, Schlaak JF. Int Immunol; 2014 Jan 21; 26(1):35-46. PubMed ID: 24065781 [Abstract] [Full Text] [Related]